accutane verdict

Roche scores Accutane victory with reversal of $25M verdict

Roche has been on a legal roller coaster with its acne drug Accutane. Facing thousands of claims that the drug triggers inflammatory bowel disease, the Swiss drugmaker is now enjoying a high point, as an appeals court reversed a $25 million verdict against the company.

In a lawsuit over a patient who developed Crohn’s disease while taking the drug, a New Jersey appeals court ruled that the plaintiff, Andrew McCarrell, did not file his suit in time and that a lower court mistakenly applied New Jersey state law, rather than the law in McCarrell’s home state of Alabama, the New Jersey Law Journal reports. The court used a precedent laid out in a 2012 Supreme Court ruling in favor of Johnson & Johnson, which dismissed a suit over a faulty stent after finding that lower courts applied the wrong state law.

This is not the first time the court has overturned a verdict over McCarrell’s Accutane claims. In 2007, a court awarded McCarrell $2.7 million, but the drugmaker ultimately got the verdict reversed, based on an issue with evidence. McCarrell won the $25 million verdict after a 2010 retrial.The appeals court decision is “very disappointing,” David Buchanan, McCarrell’s lawyer, told the NJLJ. McCarrell has fought Roche for 12 years over “permanent and devastating injuries” he got from using Accutane, 

Judge Upholds $25M Award in Accutane Bowel Disease Lawsuit

New Jersey judge has rejected Roche’s request for a new trial or reduction of a jury’s award of more than $25 million in damages for a man who developed severe inflammatory bowel disease from Accutane.

In an order issued last week, Judge Carol Higbee denied Roche’s request for a new trial or remittitur in a case brought by Andrew McCarrell, which was one of the first Accutane lawsuits in the United States to reach a jury.

McCarrell’s Accutane bowel disease suit was originally filed in 2003 and first went to trial in April 2007, resulting in a jury award of $2,619,000. However, following an appeal the verdict was overturned and the case was remanded for a new trial so that Roche would be permitted to introduce evidence on the total number of Accutane uses.

Following a second trial in January 2010, another New Jersey state court jury awarded McCarrell $159,540.19 to cover his medical bills and another $25 million in compensation for pain and suffering damages caused by Accutane.

Accutane Lawsuit Over Inflammatory Bowel Disease Results in $25M Verdict

A New Jersey jury has awarded $25.16 million in damages in an Accutane lawsuit, which alleged that the acne drug caused the plaintiff to develop inflammatory bowel disease.
The verdict was handed down this week in a New Jersey Superior Court, following the retrial of a case brought by Andrew McCarrell, 38, of Birmingham, Alabama. McCarrell originally won a $2.62 million award against Roche in 2007, but the company got that verdict overturned and the case was sent back for a retrial.

Roche faces nearly 1,000 lawsuits over Accutane, which has been associated with bowel problems, depression and birth defects. All of the lawsuits include allegations that Roche failed to adequately warn users about potential Accutane side effects. The company has lost all six cases that have gone to trial so far, with verdicts totaling $56 million, according to a report by Bloomberg News. One of those verdicts, with a $7.2 million award, has been overturned by a Florida appeals court.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in a plaintiffs’ legal claim. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for search and marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408